United States (US) Orexin Receptor Antagonists Market (2025-2031) | Industry, Outlook, Size & Revenue, Forecast, Analysis, Companies, Value, Share, Segmentation, Growth, Trends, Competitive Landscape

Market Forecast By Dosage (5mg, 10mg, 15mg, 20mg), By Drugs (Suvorexant, Lemborexant, Others), By Application (Insomnia, Depression, Anxiety, Others), By End-Users (Hospitals, Homecare, Speciality Centres, Others) And Competitive Landscape
Product Code: ETC9972291 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United States (US) Orexin Receptor Antagonists Market Outlook
  • Market Size of United States (US) Orexin Receptor Antagonists Market, 2024
  • Forecast of United States (US) Orexin Receptor Antagonists Market, 2031
  • Historical Data and Forecast of United States (US) Orexin Receptor Antagonists Revenues & Volume for the Period 2021- 2031
  • United States (US) Orexin Receptor Antagonists Market Trend Evolution
  • United States (US) Orexin Receptor Antagonists Market Drivers and Challenges
  • United States (US) Orexin Receptor Antagonists Price Trends
  • United States (US) Orexin Receptor Antagonists Porter's Five Forces
  • United States (US) Orexin Receptor Antagonists Industry Life Cycle
  • Historical Data and Forecast of United States (US) Orexin Receptor Antagonists Market Revenues & Volume By Dosage for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Orexin Receptor Antagonists Market Revenues & Volume By 5mg for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Orexin Receptor Antagonists Market Revenues & Volume By 10mg for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Orexin Receptor Antagonists Market Revenues & Volume By 15mg for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Orexin Receptor Antagonists Market Revenues & Volume By 20mg for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Orexin Receptor Antagonists Market Revenues & Volume By Drugs for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Orexin Receptor Antagonists Market Revenues & Volume By Suvorexant for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Orexin Receptor Antagonists Market Revenues & Volume By Lemborexant for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Orexin Receptor Antagonists Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Orexin Receptor Antagonists Market Revenues & Volume By Application for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Orexin Receptor Antagonists Market Revenues & Volume By Insomnia for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Orexin Receptor Antagonists Market Revenues & Volume By Depression for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Orexin Receptor Antagonists Market Revenues & Volume By Anxiety for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Orexin Receptor Antagonists Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Orexin Receptor Antagonists Market Revenues & Volume By End-Users for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Orexin Receptor Antagonists Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Orexin Receptor Antagonists Market Revenues & Volume By Homecare for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Orexin Receptor Antagonists Market Revenues & Volume By Speciality Centres for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Orexin Receptor Antagonists Market Revenues & Volume By Others for the Period 2021- 2031
  • United States (US) Orexin Receptor Antagonists Import Export Trade Statistics
  • Market Opportunity Assessment By Dosage
  • Market Opportunity Assessment By Drugs
  • Market Opportunity Assessment By Application
  • Market Opportunity Assessment By End-Users
  • United States (US) Orexin Receptor Antagonists Top Companies Market Share
  • United States (US) Orexin Receptor Antagonists Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Orexin Receptor Antagonists Company Profiles
  • United States (US) Orexin Receptor Antagonists Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United States (US) Orexin Receptor Antagonists Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) Orexin Receptor Antagonists Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Orexin Receptor Antagonists Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Orexin Receptor Antagonists Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Orexin Receptor Antagonists Market - Industry Life Cycle

3.4 United States (US) Orexin Receptor Antagonists Market - Porter's Five Forces

3.5 United States (US) Orexin Receptor Antagonists Market Revenues & Volume Share, By Dosage, 2021 & 2031F

3.6 United States (US) Orexin Receptor Antagonists Market Revenues & Volume Share, By Drugs, 2021 & 2031F

3.7 United States (US) Orexin Receptor Antagonists Market Revenues & Volume Share, By Application, 2021 & 2031F

3.8 United States (US) Orexin Receptor Antagonists Market Revenues & Volume Share, By End-Users, 2021 & 2031F

4 United States (US) Orexin Receptor Antagonists Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of sleep disorders in the United States

4.2.2 Growing awareness about the importance of sleep health

4.2.3 Continuous research and development in the field of orexin receptor antagonists

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for drug approval

4.3.2 High cost associated with the development and commercialization of orexin receptor antagonists

5 United States (US) Orexin Receptor Antagonists Market Trends

6 United States (US) Orexin Receptor Antagonists Market, By Types

6.1 United States (US) Orexin Receptor Antagonists Market, By Dosage

6.1.1 Overview and Analysis

6.1.2 United States (US) Orexin Receptor Antagonists Market Revenues & Volume, By Dosage, 2021- 2031F

6.1.3 United States (US) Orexin Receptor Antagonists Market Revenues & Volume, By 5mg, 2021- 2031F

6.1.4 United States (US) Orexin Receptor Antagonists Market Revenues & Volume, By 10mg, 2021- 2031F

6.1.5 United States (US) Orexin Receptor Antagonists Market Revenues & Volume, By 15mg, 2021- 2031F

6.1.6 United States (US) Orexin Receptor Antagonists Market Revenues & Volume, By 20mg, 2021- 2031F

6.2 United States (US) Orexin Receptor Antagonists Market, By Drugs

6.2.1 Overview and Analysis

6.2.2 United States (US) Orexin Receptor Antagonists Market Revenues & Volume, By Suvorexant, 2021- 2031F

6.2.3 United States (US) Orexin Receptor Antagonists Market Revenues & Volume, By Lemborexant, 2021- 2031F

6.2.4 United States (US) Orexin Receptor Antagonists Market Revenues & Volume, By Others, 2021- 2031F

6.3 United States (US) Orexin Receptor Antagonists Market, By Application

6.3.1 Overview and Analysis

6.3.2 United States (US) Orexin Receptor Antagonists Market Revenues & Volume, By Insomnia, 2021- 2031F

6.3.3 United States (US) Orexin Receptor Antagonists Market Revenues & Volume, By Depression, 2021- 2031F

6.3.4 United States (US) Orexin Receptor Antagonists Market Revenues & Volume, By Anxiety, 2021- 2031F

6.3.5 United States (US) Orexin Receptor Antagonists Market Revenues & Volume, By Others, 2021- 2031F

6.4 United States (US) Orexin Receptor Antagonists Market, By End-Users

6.4.1 Overview and Analysis

6.4.2 United States (US) Orexin Receptor Antagonists Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 United States (US) Orexin Receptor Antagonists Market Revenues & Volume, By Homecare, 2021- 2031F

6.4.4 United States (US) Orexin Receptor Antagonists Market Revenues & Volume, By Speciality Centres, 2021- 2031F

6.4.5 United States (US) Orexin Receptor Antagonists Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) Orexin Receptor Antagonists Market Import-Export Trade Statistics

7.1 United States (US) Orexin Receptor Antagonists Market Export to Major Countries

7.2 United States (US) Orexin Receptor Antagonists Market Imports from Major Countries

8 United States (US) Orexin Receptor Antagonists Market Key Performance Indicators

8.1 Number of clinical trials conducted for orexin receptor antagonists in the United States

8.2 Adoption rate of orexin receptor antagonists by healthcare providers

8.3 Patient adherence and compliance rates to orexin receptor antagonist therapy

9 United States (US) Orexin Receptor Antagonists Market - Opportunity Assessment

9.1 United States (US) Orexin Receptor Antagonists Market Opportunity Assessment, By Dosage, 2021 & 2031F

9.2 United States (US) Orexin Receptor Antagonists Market Opportunity Assessment, By Drugs, 2021 & 2031F

9.3 United States (US) Orexin Receptor Antagonists Market Opportunity Assessment, By Application, 2021 & 2031F

9.4 United States (US) Orexin Receptor Antagonists Market Opportunity Assessment, By End-Users, 2021 & 2031F

10 United States (US) Orexin Receptor Antagonists Market - Competitive Landscape

10.1 United States (US) Orexin Receptor Antagonists Market Revenue Share, By Companies, 2024

10.2 United States (US) Orexin Receptor Antagonists Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All